Addressing the Risks of Chemo-Induced Myelosuppression in SCLC | VuMedi

Addressing the Risks of Chemo-Induced Myelosuppression in SCLC

Addressing the Risks of Chemo-Induced Myelosuppression in SCLC

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Icahn School of Medicine at Mount Sinai

Leveraging SCLC Subtypes and Other Biomarkers

By Icahn School of Medicine at Mount Sinai FEATURING Fred Hirsch

By Icahn School of Medicine at Mount Sinai FEATURING Fred Hirsch

285 views

May 18, 2023

Comments 0

Login to view comments. Click here to Login